Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: Which one to use?;Concentrados de plaquetas procedentes de sangre total (buffy coat) u obtenidos por aféresis; ¿qué producto emplear?

Medicina Clinica

Volumn 138, Issue 12, 2012, Pages 528-533

  Lozano, María Luisa ^a   Rivera, José ^a   Vicente, Vicente ^a  

^a HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

Apheresis; Donations; Platelet concentrates

Indexed keywords

THROMBOCYTE CONCENTRATE;

APHERESIS; ARTICLE; BLEEDING; BLOOD BUFFY COAT; BLOOD DONOR; BLOOD SAFETY; COST EFFECTIVENESS ANALYSIS; EUROPE; HUMAN; RECIPIENT; RISK ASSESSMENT; THROMBOCYTOPENIA; THROMBOCYTOPHERESIS; VIRUS TRANSMISSION;

EID: 84859906134     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.05.008     Document Type: Review

References (54)

1. D.C. Buhrkuhl An update on platelet transfusion in hemato-oncology supportive care Transfusion 50 2010 2266 2276
2. R.R. Vassallo, and S. Murphy A critical comparison of platelet preparation methods Curr Opin Hematol 13 2006 323 330 (Pubitemid 44168452)
3. E. Levin, B. Culibrk, M.I. Gyöngyössy-Issa, S. Weiss, K. Scammell, and W. LeFresne Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production Transfusion 48 2008 2331 2337
4. E.C. Vamvakas The relative safety of pooled whole-blood-derived platelets prepared by the buffy-coat method versus single-donor (apheresis) platelets Clin Lab 56 2010 263 279
5. G. Andreu, J. Vasse, I. Sandid, R. Tardivel, and G. Semana Use of random versus apheresis platelet concentrates Transfus Clin Biol 14 2007 514 521
6. M.A. Silva, K.R. Gregory, M.A. Carr-Greer, J.A. Holmberg, M.J. Kuehnert, and M.E. Brecher Task Force. Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey Transfusion 46 2006 636 641
7. M.L. Lozano, and V. Vicente Transfusión de plaquetas; ¿concentrados procedentes de un único o de múltiples donantes? Med Clin (Barc) 122 2004 145 149
8. L. Eriksson, J. Kristensen, K. Olsson, J. Bring, and C.F. Högman Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coats and apheresis Vox Sang 70 1996 69 75
9. C.A. Akkök, L. Brinch, G.F. Lauritzsen, B.G. Solheim, and J. Kjeldsen-Kragh Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy Vox Sang 93 2007 42 48 (Pubitemid 46850014)
10. H. Schrezenmeier, and E. Seifried Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang 99 2010 1 15
11. a ed. Comité de acreditación en transfusión. Asociación Española de Hematología y Hemoterapia. Sociedad Española de Transfusión Sanguínea; 2006.
12. J. Rivera, M.L. Lozano, and V. Vicente In vitro changes of platelet parameters: lessons from blood banking Methods Mol Biol 273 2004 57 72
13. P. Krailadsiri, and J. Seghatchian Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets Vox Sang 78 2000 171 175
14. A.M. Albanyan, P. Harrison, and M.F. Murphy Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days Transfusion 49 2009 108 117
15. A. Skripchenko, J. Kurtz, G. Moroff, and S.J. Wagner Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage Transfusion 48 2008 1469 1477
16. P. Jilma-Stohlawetz, N. Hergovich, M. Homoncik, L. Dzirlo, M. Horvath, and M. Janisiw Impaired platelet function among platelet donors Thromb Haemost 86 2001 880 886 (Pubitemid 32834200)
17. N.M. Heddle, D.M. Arnold, D. Boye, K.E. Webert, I. Resz, and L.J. Dumont Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review Transfusion 48 2008 1447 1458
18. H. Enright, K. Davis, T. Gernsheimer, J.J. McCullough, R. Woodson, and S.J. Slichter Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial Transfusion 43 2003 1545 1552 (Pubitemid 37371824)
19. S.J. Slichter, K. Davis, H. Enright, H. Braine, T. Gernsheimer, and K.J. Kao Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients Blood 105 2005 4106 4114 (Pubitemid 40656162)
20. M.R. Kelher, T. Masuno, E.E. Moore, S. Damle, X. Meng, and Y. Song Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model Blood 113 2009 2079 2087
21. D. Van Stein, E.A. Beckers, K. Sintnicolaas, L. Porcelijn, F. Danovic, and J.A. Wollersheim Transfusion-related acute lung injury reports in the Netherlands: an observational study Transfusion 50 2010 213 220
22. D. Devine, C. Jenkins, D. Howe, and M. Goldman Relative safety of buffy coat platelet pools Transfusion 50 2010 1591 1592
23. H. Mohr, A. Bayer, U. Gravemann, and T.H. Muller Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates Transfusion 46 2006 949 955 (Pubitemid 43800913)
24. H. Schrezenmeier, G. Walther-Wenke, T.H. Muller, F. Weinauer, A. Younis, and T. Holland-Letz Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets Transfusion 47 2007 644 652 (Pubitemid 46449625)
25. C.P. Larsen, F. Ezligini, N.O. Hermansen, and J. Kjeldsen-Kragh Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results Vox Sang 88 2005 93 97 (Pubitemid 40362924)
26. D. De Korte, J. Curvers, W.L. de Kort, T. Hoekstra, C.L. van der Poel, and E.A. Beckers Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands Transfusion 46 2006 476 545
27. International Forum Haemovigilance Vox Sang 90 2006 207 241
28. E. Vamvakas, and M.A. Blajchman Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention Blood 113 2009 3406 3417
29. H.G. Heuft, W. Mende, and R. Blasczyk A general change of the platelet transfusion policy from apheresis platelet concentrates to pooled platelet concentrates is associated with a sharp increase in donor exposure and infection rates Transfus Med Hemother 35 2008 106 113 (Pubitemid 351555902)
30. E.C. Vamvakas Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks Transfusion 49 2009 2743 2758
31. S.L. Stramer, F.B. Hollinger, L.M. Katz, S. Kleinman, P.S. Metzel, and K.R. Gregory Emerging infectious disease agents and their potential threat to transfusion safety Transfusion 49 Suppl 2 2009 1S 29S
32. R. López-Vélez, M.C. Turrientes, C. Garrón, P. Montilla, R. Navajas, and S. Fenoy Microsporidiosis in travelers with diarrhea from the Tropics J Travel Med 6 1999 223 227
33. J. McCullough, D.H. Vesole, R.J. Benjamin, S.J. Slichter, A. Pineda, and E. Snyder Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial Blood 104 2004 1534 1541 (Pubitemid 39166535)
34. J.L. Kerkhoffs, W.L. van Putten, V.M. Novotny, P.A. Te Boekhorst, M.R. Schipperus, J.J. Zwaginga Dutch-Belgian HOVON cooperative group Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction Br J Haematol 150 2010 209 217
35. A.M. Galan, M. Lozano, P. Molina, F. Navalon, S. Marschner, and R. Goodrich Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function Transfusion 51 2011 808 815
36. M. Lozano, F. Knutson, R. Tardivel, J. Cid, R.M. Maymó, and H. Löf A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalend prior to transfusion and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion Br J Haematol 153 2011 393 401
37. J.L. Winters Complications of donor apheresis J Clin Apher 21 2006 132 141
38. T.B. Wiltbank, and G.F. Giordano The safety profile of automated collections: an analysis of more than 1 million collections Transfusion 47 2007 1002 1005 (Pubitemid 46802077)
39. C.D. Bolan, S.A. Cecco, Y.Y. Yau, R.A. Wesley, J.M. Oblitas, and N.N. Rehak Randomized placebo- controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects Transfusion 43 2003 1414 1422 (Pubitemid 37322502)
40. M. Dettke, C. Buchta, C. Bieglmayer, F. Kainberger, M. Macher, and P. Höcker Short- and longterm effects of citrate on bone metabolism and bone mineral density in healthy plateletpheresis donors [comunicación a congreso] J Clin Apher 18 2003 87
41. G.J. Despotis, L.T. Goodnough, M. Dynis, D. Baorto, and E. Spitznagel Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program Vox Sang 77 1999 24 32 (Pubitemid 29408264)
42. M. Dettke, M. Hlousek, M. Kurz, G. Leitner, K. Rosskopf, and G. Stiegler Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresis Transfusion 38 1998 449 453 (Pubitemid 28287501)
43. H.E. Tibbles, C.S. Navara, M.A. Hupke, A.O. Vassilev, and F.M. Uckun Thrombopoietin induces p-selectin expression on platelets and subsequent platelet/leukocyte interactions Biochem Biophys Res Commun 292 2002 987 991 (Pubitemid 34687302)
44. O.E. Van, Y.P. Wu, J.G. Pouwels, M.J. Ijsseldijk, J.J. Sixma, and J.W. Akkerman Thrombopoietin increases platelet adhesion under flow and decreases rolling Br J Haematol 121 2003 482 490 (Pubitemid 36628342)
45. J.L. Lyche, A.C. Gutleb, A. Bergman, G.S. Eriksen, A.J. Murk, and E. Ropstad Reproductive and developmental toxicity of phthalates J Toxicol Environ Health B Crit Rev 12 2009 225 249
46. C. Buchta, C. Bittner, P. Hocker, M. Macher, R. Schmid, and C. Seger Donor exposure to the plasticizer di(2-ethyl-hexyl)phthalate during plateletpheresis Transfusion 43 2003 1115 1120 (Pubitemid 37022372)
47. H.M. Koch, J. Angerer, H. Drexler, R. Eckstein, and V. Weisbach Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors Int J Hyg Environ Health 208 2005 489 498 (Pubitemid 41527207)
48. I. Lopez-Plaza, J. Weissfeld, and D.J. Triulzi The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets Transfusion 39 1999 925 932 (Pubitemid 29439786)
49. R.A. Hirth, M.E. Chernew, E. Miller, A.M. Fendrick, and W.G. Weissert Willingness to pay for a quality-adjusted life year: In search of a standard Med Decis Making 20 2000 332 342 (Pubitemid 30479101)
50. B.R. Jackson, M.P. Busch, S.L. Stramer, and J.P. AuBuchon The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Transfusion 43 2003 721 729 (Pubitemid 36629116)
51. A. Pereira, and C.A. Sanz Model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols Transfusion 40 2000 1182 1191
52. P.W. Stone, S. Teutsch, R.H. Chapman, C. Bell, S.J. Goldie, and P.J. Neumann Cost-utility analyses of clinical preventive services: published ratios, 1976-1997 Am J Prev Med 19 2000 15 23 (Pubitemid 30364993)
53. M.J. Postma, M. van Hulst, J.T.M. De Wolf, M. Botteman, and U. Staginnus Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands Transfus Med 15 2005 379 387 (Pubitemid 43942845)
54. C.E. Bell, M.F. Botteman, X. Gao, J.L. Weissfeld, M.J. Postma, and C.L. Pashos Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States Clin Ther 25 2003 2464 2486 (Pubitemid 37267253)